GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Imaging Biometrics Ltd (LSE:IBAI) » Definitions » Tariff Resilience Score

Imaging Biometrics (LSE:IBAI) Tariff Resilience Score : 0/10 (As of Jul. 19, 2025)


View and export this data going back to 1993. Start your Free Trial

What is Imaging Biometrics Tariff Resilience Score?

Imaging Biometrics has the Tariff Resilience Score of 0, which implies that the company might have .

Imaging Biometrics has

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Imaging Biometrics might have .


Imaging Biometrics  (LSE:IBAI) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Imaging Biometrics Tariff Resilience Score Related Terms

Thank you for viewing the detailed overview of Imaging Biometrics's Tariff Resilience Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Imaging Biometrics Business Description

Traded in Other Exchanges
N/A
Address
IFC 5, Channel Islands, Saint Helier, JEY, JE1 1ST
Imaging Biometrics Ltd formerly, IQ-AI Ltd operates as an investment company. The principal activity of the group is the provision of convenient, cost-effective, and clinical treatments to patients in the field of medical imaging diagnostics, based on technologies. Its geographical segment includes Jersey and the United States of America and reportable segments are holding company expenses and medical software. The company derives a majority of revenue from the United States of America. It also supplies medical technology solutions and has a neuroimaging product portfolio.

Imaging Biometrics Headlines

No Headlines